Research Paper Volume 12, Issue 4 pp 3899—3910

Clinical burden of autosomal dominant polycystic kidney disease

Figure 1. The association of medication dose and duration with various outcomes. Risk of all-cause mortality according to dosage (A) or cumulative (B) of Allopurinol use. Risk of ESRD according to dosage (C) or cumulative (D) of Statins use. Risk of ESRD according to dosage (E) or cumulative (F) of Pentoxiphylline use. Adjusted for age, gender, geography, all comorbidity and medications. ESRD: end-stage renal disease; HR: hazard ratio; CI: Confidence interval. * p<0.05, ** p <0.01.